These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 19823023)

  • 1. The Alox5 gene is a novel therapeutic target in cancer stem cells of chronic myeloid leukemia.
    Chen Y; Li D; Li S
    Cell Cycle; 2009 Nov; 8(21):3488-92. PubMed ID: 19823023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of the Alox5 gene impairs leukemia stem cells and prevents chronic myeloid leukemia.
    Chen Y; Hu Y; Zhang H; Peng C; Li S
    Nat Genet; 2009 Jul; 41(7):783-92. PubMed ID: 19503090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and cellular bases of chronic myeloid leukemia.
    Chen Y; Peng C; Li D; Li S
    Protein Cell; 2010 Feb; 1(2):124-32. PubMed ID: 21203982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted therapy of chronic myeloid leukemia.
    Sullivan C; Peng C; Chen Y; Li D; Li S
    Biochem Pharmacol; 2010 Sep; 80(5):584-91. PubMed ID: 20470758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The implication of cancer progenitor cells and the role of epigenetics in the development of novel therapeutic strategies for chronic myeloid leukemia.
    Tortorella SM; Hung A; Karagiannis TC
    Antioxid Redox Signal; 2015 Jun; 22(16):1425-62. PubMed ID: 25366930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erosion of the chronic myeloid leukaemia stem cell pool by PPARγ agonists.
    Prost S; Relouzat F; Spentchian M; Ouzegdouh Y; Saliba J; Massonnet G; Beressi JP; Verhoeyen E; Raggueneau V; Maneglier B; Castaigne S; Chomienne C; Chrétien S; Rousselot P; Leboulch P
    Nature; 2015 Sep; 525(7569):380-3. PubMed ID: 26331539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel therapeutic agents against cancer stem cells of chronic myeloid leukemia.
    Chen Y; Peng C; Sullivan C; Li D; Li S
    Anticancer Agents Med Chem; 2010 Feb; 10(2):111-5. PubMed ID: 20184539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Why do chronic myelogenous leukemia stem cells survive allogeneic stem cell transplantation or imatinib: does it really matter?
    Goldman J; Gordon M
    Leuk Lymphoma; 2006 Jan; 47(1):1-7. PubMed ID: 16321820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LSK derived LSK- cells have a high apoptotic rate related to survival regulation of hematopoietic and leukemic stem cells.
    Peng C; Chen Y; Shan Y; Zhang H; Guo Z; Li D; Li S
    PLoS One; 2012; 7(6):e38614. PubMed ID: 22675576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting methyltransferase PRMT5 eliminates leukemia stem cells in chronic myelogenous leukemia.
    Jin Y; Zhou J; Xu F; Jin B; Cui L; Wang Y; Du X; Li J; Li P; Ren R; Pan J
    J Clin Invest; 2016 Oct; 126(10):3961-3980. PubMed ID: 27643437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A tumor suppressor function of the Msr1 gene in leukemia stem cells of chronic myeloid leukemia.
    Chen Y; Sullivan C; Peng C; Shan Y; Hu Y; Li D; Li S
    Blood; 2011 Jul; 118(2):390-400. PubMed ID: 21596859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting multiple kinase pathways in leukemic progenitors and stem cells is essential for improved treatment of Ph+ leukemia in mice.
    Hu Y; Swerdlow S; Duffy TM; Weinmann R; Lee FY; Li S
    Proc Natl Acad Sci U S A; 2006 Nov; 103(45):16870-5. PubMed ID: 17077147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Blk pathway functions as a tumor suppressor in chronic myeloid leukemia stem cells.
    Zhang H; Peng C; Hu Y; Li H; Sheng Z; Chen Y; Sullivan C; Cerny J; Hutchinson L; Higgins A; Miron P; Zhang X; Brehm MA; Li D; Green MR; Li S
    Nat Genet; 2012 Jul; 44(8):861-71. PubMed ID: 22797726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting chronic myeloid leukemia stem cells.
    Helgason GV; Young GA; Holyoake TL
    Curr Hematol Malig Rep; 2010 Apr; 5(2):81-7. PubMed ID: 20425400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Pten in leukemia stem cells.
    Peng C; Chen Y; Li D; Li S
    Oncotarget; 2010 Jun; 1(2):156-160. PubMed ID: 21297225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting protein lysine methyltransferase G9A impairs self-renewal of chronic myelogenous leukemia stem cells via upregulation of SOX6.
    Zhou M; Zhang X; Liu C; Nie D; Li S; Lai P; Jin Y
    Oncogene; 2021 May; 40(20):3564-3577. PubMed ID: 33931742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of cancer stem cells in chronic myeloid leukaemia.
    Jørgensen HG; Holyoake TL
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):1347-51. PubMed ID: 17956348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. beta-Catenin is essential for survival of leukemic stem cells insensitive to kinase inhibition in mice with BCR-ABL-induced chronic myeloid leukemia.
    Hu Y; Chen Y; Douglas L; Li S
    Leukemia; 2009 Jan; 23(1):109-16. PubMed ID: 18818703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia.
    Naka K; Hoshii T; Muraguchi T; Tadokoro Y; Ooshio T; Kondo Y; Nakao S; Motoyama N; Hirao A
    Nature; 2010 Feb; 463(7281):676-80. PubMed ID: 20130650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arachidonate 15-lipoxygenase is required for chronic myeloid leukemia stem cell survival.
    Chen Y; Peng C; Abraham SA; Shan Y; Guo Z; Desouza N; Cheloni G; Li D; Holyoake TL; Li S
    J Clin Invest; 2014 Sep; 124(9):3847-62. PubMed ID: 25105362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.